Steinhart Richard I
SEC insider (Form 3/4/5 filer). CIK 0001293789. Director at Actinium Pharmaceuticals, Inc. (ATNM) and 2 other issuers. 41 reported Form 4/5 transactions since Sep 2024; latest on Sep 2, 2026. Located in NEW YORK, NY.
Companies Steinhart Richard I has filed insider reports for
- Actinium Pharmaceuticals, Inc. (ATNM): Director
- BioXcel Therapeutics, Inc. (BTAI): Officer, Chief Financial Officer
- ATOSSA THERAPEUTICS, INC. (ATOS): Director
Steinhart Richard I
CIK: 0001293789
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (41 total)
- Sep 2, 2026ATNM
Actinium Pharmaceuticals, Inc.
AwardDirect62.8K shares- - Jun 15, 2026BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect35 shares- - May 20, 2026BTAI
BioXcel Therapeutics, Inc.
SaleDirect6.8K shares at avg. $1.08$7K - May 12, 2026ATOS
ATOSSA THERAPEUTICS, INC.
AwardDirect10K shares- - May 4, 2026BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect17.5K shares- - May 1, 2026BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect9K shares- - Mar 15, 2026BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect35 shares- - Mar 14, 2026BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect33 shares- - Jan 1, 2026BTAI
BioXcel Therapeutics, Inc.
AwardDirectRestricted Stock Units
70K shares- - Dec 15, 2025BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect35 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 |  ATNM Actinium Pharmaceuticals, Inc. | Award | 62,800 | - | $0 | Direct |
| Jun 15, 2026 |  BTAI BioXcel Therapeutics, Inc. | Exercise | 35 | - | $0 | Direct |
| May 20, 2026 | BTAI BioXcel Therapeutics, Inc. | Sale | 6,845 | $1.08 | $7,427 | Direct |
| May 12, 2026 |  ATOS ATOSSA THERAPEUTICS, INC. | Award | 10,000 | - | $0 | Direct |
| May 4, 2026 | BTAI BioXcel Therapeutics, Inc. | Exercise | 17,500 | - | $0 | Direct |
| May 1, 2026 | BTAI BioXcel Therapeutics, Inc. | Exercise | 9,000 | - | $0 | Direct |
| Mar 15, 2026 | BTAI BioXcel Therapeutics, Inc. | Exercise | 35 | - | $0 | Direct |
| Mar 14, 2026 | BTAI BioXcel Therapeutics, Inc. | Exercise | 33 | - | $0 | Direct |
| Jan 1, 2026 | BTAI BioXcel Therapeutics, Inc. | Award Restricted Stock Units | 70,000 | - | - | Direct |
| Dec 15, 2025 | BTAI BioXcel Therapeutics, Inc. | Exercise | 35 | - | - | Direct |
1-10 of 41 transactions